Metraipolis › archive › dc_45fce01ce1c5

Comparative thromboembolic risk of romiplostim versus eltrombopag in immune thrombocytopenia: a propensity score-matched cohort study — Europe PMC PMID:42393361

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42393361
DOI
10.1007/s00277-[numero omesso]-4
License (as archived)
solo-consultazione
Archived
2026-10-18T11:28:36.791Z
SHA-256 of the archived text
3b7d162503d8c4d8b55e1a9e1c2087f6af78889e6fffa6f3c84531a8908c1993
Stable URL of this page
https://metraipolis.com/documento/dc_45fce01ce1c5

How to cite

Comparative thromboembolic risk of romiplostim versus eltrombopag in immune thrombocytopenia: a propensity score-matched cohort study — Europe PMC PMID:42393361 — Europe PMC (en), https://europepmc.org/article/MED/42393361 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_45fce01ce1c5 (Metraipolis archive dc_45fce01ce1c5, sha256 3b7d162503d8c4d8b55e1a9e1c2087f6af78889e6fffa6f3c84531a8908c1993)
BibTeX
@misc{dc45fce01ce1c5,
  title = {Comparative thromboembolic risk of romiplostim versus eltrombopag in immune thrombocytopenia: a propensity score-matched cohort study — Europe PMC PMID:42393361},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42393361},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_45fce01ce1c5; sha256 3b7d162503d8c4d8b55e1a9e1c2087f6af78889e6fffa6f3c84531a8908c1993},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42393361. Agents can read the archived copy with the MCP tool read_document.